About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Runx1tm1.1Soga
targeted mutation 1.1, Seishi Ogawa
MGI:3036557
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Runx1tm1Soga/Runx1tm1.1Soga
Tg(Mx1-cre)1Cgn/0
involves: C57BL/6 * CBA MGI:3036555


Genotype
MGI:3036555
cn1
Allelic
Composition
Runx1tm1Soga/Runx1tm1.1Soga
Tg(Mx1-cre)1Cgn/0
Genetic
Background
involves: C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Runx1tm1.1Soga mutation (0 available); any Runx1 mutation (34 available)
Runx1tm1Soga mutation (0 available); any Runx1 mutation (34 available)
Tg(Mx1-cre)1Cgn mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• mutants injected with pIpC to induce expression of Cre recombinase exhibit normal myeloid cell development, neutrophil counts, hemoglobin levels, and maintenance of hematopoietic stem cells in adults
• pIpC treated mutants exhibit an increase in apoptosis of myeloid colony-forming cells
• pIpC treated mutants exhibit a significant block in the maturation of T-cell progenitors at the transition from CD44+CD25+ (double negative 2) to CD44-CD25+ (double negative 3), indicating the accumulation of immature T-cell precursors in the thymus
• the immature megakaryocytes observed in bone marrow of mutants injected with pIpC exhibit poorly demarcated membranes and a lower level of polyploidy than controls
• after injection of pIpC to induce expression of Cre recombinase, bone marrow exhibits an arrest in megakaryocytic maturation
• after injection of pIpC to induce expression of Cre recombinase, mutants exhibit an increase in hematopoietic progenitor cells
• bone marrow cells from pIpC injected mutants form more megakaryocytic (CFU-Meg), myeloid, and mixed (myeloid and erythroid) colonies in vitro than control bone marrow cells
• immediately after injection of pIpC to induce expression of Cre recombinase, mice show a decline in platelet counts to 1/3 to 1/6 of those for the control

immune system
• pIpC treated mutants exhibit a significant block in the maturation of T-cell progenitors at the transition from CD44+CD25+ (double negative 2) to CD44-CD25+ (double negative 3), indicating the accumulation of immature T-cell precursors in the thymus

cellular
• after injection of pIpC to induce expression of Cre recombinase, bone marrow exhibits an arrest in megakaryocytic maturation





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory